LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea flag South Korea · Delayed Price · Currency is KRW
194,500
-9,000 (-4.42%)
Apr 29, 2026, 3:30 PM KST

LigaChem Biosciences Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
7,415,4486,323,5713,975,2671,827,2891,092,8041,352,308
Upgrade
Market Cap Growth
116.74%59.07%117.55%67.21%-19.19%138.87%
Upgrade
Enterprise Value
6,977,1565,787,0203,458,0301,723,146929,3581,262,535
Upgrade
Last Close Price
203500.00173700.00109000.0065000.0042850.0055800.00
Upgrade
PE Ratio
--509.64---
Upgrade
Forward PE
-44.5044.5044.5044.5044.50
Upgrade
PS Ratio
52.3944.6731.5853.5232.7142.05
Upgrade
PB Ratio
13.7011.696.4512.334.985.23
Upgrade
P/TBV Ratio
18.3915.696.5412.945.195.44
Upgrade
P/FCF Ratio
--52.41---
Upgrade
P/OCF Ratio
--50.66---
Upgrade
EV/Sales Ratio
49.2940.8827.4750.4727.8239.26
Upgrade
EV/FCF Ratio
-54.69-45.59---
Upgrade
Debt / Equity Ratio
0.010.010.000.090.060.05
Upgrade
Debt / FCF Ratio
--0.01---
Upgrade
Net Debt / Equity Ratio
-0.87-0.87-0.80-0.59-0.72-0.65
Upgrade
Net Debt / EBITDA Ratio
4.724.7231.011.153.416.84
Upgrade
Net Debt / FCF Ratio
3.703.70-6.501.3713.962.79
Upgrade
Asset Turnover
0.200.200.270.150.12-
Upgrade
Inventory Turnover
96.4896.4877.9482.6466.32-
Upgrade
Quick Ratio
8.208.204.463.216.6113.35
Upgrade
Current Ratio
8.548.544.703.636.7013.45
Upgrade
Return on Equity (ROE)
-15.82%-15.82%2.04%-40.08%-18.85%-
Upgrade
Return on Assets (ROA)
-9.24%-9.24%-2.82%-22.86%-11.54%-
Upgrade
Return on Invested Capital (ROIC)
-245.76%-110.81%-19.45%-131.59%-66.23%-48.80%
Upgrade
Return on Capital Employed (ROCE)
-16.60%-16.60%-3.40%-53.00%-22.50%-10.00%
Upgrade
Earnings Yield
-1.00%-1.18%0.20%-4.03%-4.13%-1.73%
Upgrade
FCF Yield
-1.72%-2.02%1.91%-3.48%-1.03%-4.46%
Upgrade
Buyback Yield / Dilution
-4.68%-4.68%-22.36%-1.38%-16.13%-0.47%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.